A new study shows a butyrate-based supplement can help people with fatty liver disease. Participants with fatty liver and metabolic syndrome took either the supplement or a placebo for 3 months. Those taking the supplement saw significant improvements in liver health markers like FLI and reduced levels of harmful fats in the blood.

While more research is needed, these results are promising for finding new treatments for fatty liver disease.

#fattyliver #NAFLD #butyrate #metaboliscsyndrome #liverhealth #liverdisease #guthealth #nutritionresearch #supplementation #dietandhealth #zinc #vitamind

Fogacci F, Giovannini M, Di Micoli V, Grandi E, Borghi C, Cicero AFG. Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2024; 16(15):2454. https://doi.org/10.3390/nu16152454

butyrate, fatty liver disease, NAFLD, metabolic syndrome, liver steatosis, gut microbiota, short-chain fatty acids, inflammation, insulin resistance, obesity, zinc, vitamin D, clinical trial, randomized controlled trial, placebo-controlled, supplementation, dietary intervention, liver enzymes, lipid profile, quality of life, patient outcomes, hepatic fibrosis